Suchergebnisse - "Clodi, Martin"

PubPharm (19)

1

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis

enthalten in: Annals of internal medicine | 2023

von Agarwal, R. | Tu, W. | Farjat, A. | +112

2

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment : The FIDELITY Analysis

enthalten in: Diabetes care | 2022

von Rossing, P. | Anker, S. | Filippatos, G. | +112

CommentIn: Nephrology (Carlton). 2022 Dec;27(12):915-916. - PMID 36273253

3

Glucose and lipopolysaccharide differentially regulate fibroblast growth factor 21 in healthy male human volunteers - A prospective cross-over trial

enthalten in: Journal of cellular and molecular medicine | 2022

von Pohlhammer, J. | Heinzl, M. | Klammer, C. | +8

4

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use : An Analysis From the FIDELIO-DKD Study

enthalten in: Diabetes care | 2022

von Rossing, P. | Burgess, E. | Agarwal, R. | +113

ErratumIn: Diabetes Care. 2023 Sep 1;46(9):1721. - PMID 37310695

5

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA) : a randomised, double-blind, double-dummy, phase 3 study

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Danese, S. | Colombel, J. | Lukas, M. | +114

CommentIn: Lancet Gastroenterol Hepatol. 2022 Jan;7(1):2-4. - PMID 34798035

6

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY) : a phase 3, randomised, controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Peyrin-Biroulet, L. | Hart, A. | Bossuyt, P. | +114

CommentIn: Lancet Gastroenterol Hepatol. 2022 Jan;7(1):2-4. - PMID 34798035

7

Intravenous administration of LPS activates the kynurenine pathway in healthy male human subjects : a prospective placebo-controlled cross-over trial

enthalten in: Journal of neuroinflammation | 2021

von Millischer, V. | Heinzl, M. | Faka, A. | +7

8

Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial

enthalten in: American journal of nephrology | 2019

von Bakris, G. | Agarwal, R. | Anker, S. | +109

9

Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial

enthalten in: American journal of nephrology | 2019

von Ruilope, L. | Agarwal, R. | Anker, S. | +108

10

B-type natriuretic peptide increases cortisol and catecholamine concentrations in healthy subjects

enthalten in: Journal of applied physiology (Bethesda, Md. : 1985) | 2017

von Grimm, G. | Resl, M. | Heinisch, B. | +4